HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
GW 597599
Description
GW 597599, a neurokinin-1 (NK1) receptor antagonist is currently in phase II trials for chemotherapy-induced vomiting; functional dyspepsia; depression and anxiety.
No brand information found.
